Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

EPIX: Preclinical Data on Androgen Receptor N-Terminal Domain Degrader Presented at AACR…

By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT

Benzinga

Here's Why Intel CEO Believes Chip Shortage To Last Until 2024

After predicting the global chip shortage would last until 2023, Intel Corporation (NASDAQ: INTC) CEO Pat Gelsinger is now suggesting the shortage could last until at least 2024.

Benzinga

EV Week In Review: Musk's $8.5 Tesla Stock Sale, Nikola Tre Semitruck Launches, Nio's ET5 Updates, Ford Lightning Strikes And More

EV stocks continued to be under pressure in the week ending April 29, with Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) and Arrival (NASDAQ: ARVL) and Tesla, Inc.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

Gainers Rave Restaurant Gr (NASDAQ:RAVE) stock increased by 8.0% to $1.08 during Friday's after-market session. The market value of their outstanding shares is at $19.4 million.

Benzinga

12 Communication Services Stocks Moving In Friday's After-Market Session

Gainers Troika Media Group (NASDAQ:TRKA) shares rose 8.5% to $0.51 during Friday's after-market session. The market value of their outstanding shares is at $25.2 million.

Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.

Benzinga

12 Information Technology Stocks Moving In Friday's After-Market Session

Gainers Alpine 4 Holdings (NASDAQ:ALPP) stock rose 9.3% to $0.85 during Friday's after-market session. The company's market cap stands at $155.7 million.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

If You Invested $100 In Atlassian Corporation 5 Years Ago, Here's How Much You Would Have Today

Atlassian Corporation (NASDAQ:TEAM) has outperformed the market over the past 5 years by 33.59% on an annualized basis producing an average annual return of 45.11%. Currently, Atlassian Corporation has a market capitalization of $56.99 billion.

Benzinga

If You Invested $100 In Applied Materials 10 Years Ago, Here's How Much You Would Have Today

Applied Materials (NASDAQ:AMAT) has outperformed the market over the past 10 years by 13.88% on an annualized basis producing an average annual return of 25.34%. Currently, Applied Materials has a market capitalization of $97.48 billion.

Benzinga

Here's Why Analysts Are Lowering Price Targets On Amazon After Q1 Earnings

E-commerce giant Amazon.com, Inc. (NASDAQ: AMZN) reported mixed earnings Thursday and announced guidance that came in lower than analysts' estimates for the second quarter. Here's why analysts are lowering their price targets and sound more cautious moving forward.

Benzinga

Nasdaq suffers worst month since 2008 as stocks plunge on recession fears

Tech-heavy Nasdaq falls 13% over April and is now in a bear market

The Independent UK

Nasdaq falls to worst low since 2008 as stocks plunge amid recession fears

The tech-heavy index fell 4.2%, concluding its worst month since October 2008

The Independent UK

Airbnb To Let Employees 'Live And Work Anywhere' — But Here's The Fine Print

Starting in September, Airbnb Inc (NASDAQ: ABNB) employees will have the option to work from almost anywhere, the vacation rental company’s co-founder and CEO Brian Chesky wrote in a blog post on Thursday.

Benzinga

Coinbase CEO Brian Armstrong Changes Rules To Counter Insider Trading Allegations

Brian Armstrong — the CEO of major U.S.-based cryptocurrency exchange Coinbase Global Inc. (NASDAQ: COIN) — responded to insider trading accusations by changing internal rules concerning listings.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking At Riot Blockchain's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Riot Blockchain (NASDAQ:RIOT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS:

Benzinga

Marijuana Stock Movers For April 29, 2022

GAINERS: Marrone Bio Innovations (NASDAQ:MBII) shares closed up 30.57% at $1.16

Benzinga

United Therapeutics Q1 2022 Earnings Conference Call On May 4, 2022 At 09:00 AM ET

United Therapeutics (NASDAQ:UTHR) will host a conference call at 09:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend United Therapeutics (UTHR) Conference Call Follow this link to access the live webcast.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 5 Analyst Ratings Have To Say About Intel

Analysts have provided the following ratings for Intel (NASDAQ:INTC) within the last quarter:

Benzinga

Earnings Outlook For Diamondback Energy

Diamondback Energy (NASDAQ:FANG) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Diamondback Energy will report an earnings per share (EPS) of $4.57.

Benzinga

Galmed Pharmaceuticals's Earnings Outlook

Galmed Pharmaceuticals (NASDAQ:GLMD) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Galmed Pharmaceuticals will report an earnings per share (EPS) of $-0.30.

Benzinga

A Preview Of Axsome Therapeutics's Earnings

Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Axsome Therapeutics will report an earnings per share (EPS) of $-1.00.

Benzinga

Expert Ratings for Seagen

Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analyst ratings:

Benzinga

What 8 Analyst Ratings Have To Say About Pegasystems

Analysts have provided the following ratings for Pegasystems (NASDAQ:PEGA) within the last quarter:

Benzinga

Earnings Preview: trivago

trivago (NASDAQ:TRVG) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that trivago will report an earnings per share (EPS) of $0.03.

1 … 664 665 666 667

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.